J&J + Merck moves vaccine schedule ahead by 2 months!


Jim Watson/Getty

With a White House-brokered deal, vaccine giant Merck has agreed to help Johnson & Johnson boost its COVID-19 vaccine production, which is woefully behind on its manufacturing schedule.

President Joe Biden announced today that, with the new deal, the country is on track to have enough COVID-19 vaccine doses to vaccinate every adult in the country by the end of May — two months ahead of earlier plans.

Merck—a powerhouse in vaccine production, responsible for the MMR (measles, mumps, and rubella) vaccine among others—will dedicate two US facilities to making the Johnson & Johnson COVID-19 vaccine. One facility will make the vaccine and the other will provide final-stage “fill and finish” services, involving aliquoting vaccine into vials and packaging them. The help from Merck stands to perhaps double J&J’s manufacturing.

Getting what can be done on time – accomplished early.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.